Analysis in progress
Initialising…
0%
complete
This report is still being assembled — sections appear as each stage finishes. It isn't final yet.
NOTCH3
Final classification
Pathogenic
NOTCH3 c.5032G>T · p.Glu1678Ter
NOTCH3

PVS1 (very strong): NM_000435.2:c.5032G>T is a nonsense variant in exon 27 of 33, predicted to produce a premature termination codon at p.Glu1678Ter and trigger nonsense-mediated decay. NOTCH3 loss-of-function is established as a germline disease mechanism, satisfying PVS1 at very strong level under the ClinGen SVI PVS1 framework (PMC6185798).

Gene
NOTCH3
Transcript
NM_000435.2
HGVS · transcript:coding
NM_000435.2:c.5032G>T
Consequence
N/A
GRCh38
chr19:15170413 C>A
GRCh37
chr19:15281224 C>A
Basis gene-specific framework lacked a usable explicit final combination framework, so generic ACMG/AMP 2015 final-combination rules were applied as fallback; applied criteria: PVS1 very strong, PM1 moderate, PM2 supporting; combination = 1 very strong + 1 moderate + 1 supporting, which maps to Pathogenic.
gene-specific framework lacked a usable explicit final combination framework, so generic ACMG/AMP 2015 final-combination rules were applied as fallback; applied criteria: PVS1 very strong, PM1 moderate, PM2 supporting; combination = 1 very strong + 1 moderate + 1 supporting, which maps to Pathogenic.
Classification rationale
PVS1PM1PM2 Pathogenic
NOTCH3 c.5032G>T

PVS1 (very strong): NM_000435.2:c.5032G>T is a nonsense variant in exon 27 of 33, predicted to produce a premature termination codon at p.Glu1678Ter and trigger nonsense-mediated decay. NOTCH3 loss-of-function is established as a germline disease mechanism, satisfying PVS1 at very strong level under the ClinGen SVI PVS1 framework (PMC6185798).1 PM1 (moderate): The nonsense variant truncates the NOTCH3 intracellular domain, removing the ankyrin repeat domain essential for transcriptional activation and the PEST domain that regulates protein stability. These are well-characterized, functionally critical domains.2 PM2 (supporting): The variant is absent from gnomAD v2.1, v4.1, and gnomAD-Canada (AF=0), meeting the PM2 threshold of <0.1% allele frequency in population databases.3

PVS1 + PM1 + PM2 Pathogenic
Gene diagram · NM_000435.2 · variants mapped to exon structure
NOTCH3 NM_000435.2
Fetching transcript structure from UCSC…
Applied criteria · 3 applied · 17 assessed
Applied · 3
Strength Supporting Moderate Strong Very strong
PVS1 very strong Pathogenic
Nonsense variant NM_000435.2:c.5032G>T (p.Glu1678Ter) in exon 27 of 33 introduces a premature termination codon predicted to trigger nonsense-mediated decay or produce a truncated protein lacking the C-terminal 644 amino acids including the ANK repeat and PEST domains. NOTCH3 loss-of-function is established as a germline disease mechanism by recent literature demonstrating recessive LoF variants cause early-onset arteriopathy and trans LoF variants modify CADASIL severity. Assessed under ClinGen SVI PVS1 framework (PMC6185798).
Nonsense variant at c.5032 (exon 27/33) predicted to trigger NMDNOTCH3 LoF mechanism supported by germline disease literature (PMID:41196431PMID:41947304)
PM1 moderate Pathogenic
The nonsense variant at p.Glu1678Ter is located in the NOTCH3 intracellular domain and truncates the protein, removing the ankyrin repeat domain and the PEST degradation domain — both well-characterized functional regions essential for NOTCH3 transcriptional activity and protein turnover. The truncated ICD is critical for Notch signaling, consistent with PM1 domain-level application.
Truncation removes ANK repeat domain and PEST domain in the NOTCH3 ICDANK repeats required for transcriptional activationPEST domain regulates protein stability
PM2 supporting Pathogenic
NM_000435.2:c.5032G>T is absent from gnomAD v2.1, v4.1, and gnomAD-Canada, with an allele frequency of 0 in all population databases. This is well below the PM2 threshold of <0.1% for non-VCEP frameworks.
Absent from gnomAD v2.1 (AF = 0)Absent from gnomAD v4.1 (AF = 0)Absent from gnomAD-Canada v1.0 (AF = 0)
Assessed · not applied
Pathogenic
PS2 No de novo observation was identified for NM_000435.2:c.5032G>T in any source.
PS3 No variant-specific functional data exists for NM_000435.2:c.5032G>T.
PS4 The variant has not been reported in affected individuals.
PM5 No pathogenic missense variant at codon 1678 was identified.
PM6 No de novo observation was identified for NM_000435.2:c.5032G>T.
PP1 No segregation data are available for this variant.
PP3 BayesDel score of 0.66 is consistent with a deleterious prediction, but in silico pathogenicity predictors are calibrated for missense variants and are not validated for nonsense variants.
PP4 No patient phenotype or family history data were submitted with this variant.
PP5 NM_000435.2:c.5032G>T is absent from ClinVar.
Benign
BA1 The variant is absent from gnomAD v2.1, v4.1, and gnomAD-Canada (AF=0).
BS1 The variant is absent from all population databases (AF=0).
BS2 The variant is absent from gnomAD; no homozygous observations exist in healthy adults.
BS3 No functional data demonstrating a neutral or benign effect for NM_000435.2:c.5032G>T were identified.
BS4 No segregation data are available to assess lack of cosegregation with disease.
BP2 No observation of this variant in trans with a pathogenic NOTCH3 variant or in cis with a pathogenic variant in any inheritance pattern was identified.
BP5 No alternative molecular basis for disease was identified because no patient case data with a different causative variant were available for comparison.
BP6 NM_000435.2:c.5032G>T is absent from ClinVar.
N/A · 5 PS1 · PP2 · BP1 · BP4 · BP7
Research & evidence
Population frequency · supports pathogenic
gnomAD v4.1 screenshot
gnomAD v4.1
gnomAD v2.1 screenshot
gnomAD v2.1
v4.1
Absent from gnomAD v4.1.
v2.1
Absent from gnomAD v2.1.
🇨🇦 CA
Absent from gnomAD-Canada v1.0.
Allele frequency by ancestry
three datasets · side by side
gnomAD v4.1
Absent · 0 / ?
0 hom
Not observed in any ancestry group.
gnomAD v2.1
Absent · 0 / ?
0 hom
Not observed in any ancestry group.
gnomAD Canada 🇨🇦
Absent · 0 / ?
0 hom
Not observed in any ancestry group.
ClinVar screenshot
ClinVar
This variant is absent from ClinVar.
SpliceAI screenshot
In silico
SpliceAI predicts no significant splice impact for this variant (max delta score = 0.16). BayesDel score = 0.66.
Functional / OncoKB screenshot
Functional Likely Oncogenic
OncoKB identified variant-specific curated literature and context relevant to functional review; biological-effect context: Likely Loss-of-function; curated oncogenicity label: Likely Oncogenic.
OncoKB ↗
COSMIC screenshot
COSMIC
Cancer hotspots screenshot
Cancer hotspots
Somatic evidence Not in COSMIC / hotspots
COSMIC
This variant does not lie in a statistically significant hotspot. This variant has not previously been reported in somatic cancers (COSMIC).
Hotspots
This variant does not lie in a statistically significant hotspot.
Sources & reference links
8Sources
ClinVar
gnomAD v2.1
gnomAD v4.1
gnomAD-Canada
SpliceAI
OncoKB
COSMIC
Cancer hotspots
Triaged references · 2 PMIDs not cited in assessment
19825845 ↗ Mutations in NOTCH3 cause the formation and retention of aggregates in the endoplasmic reticulum, leading to impaired cell proliferation. ONCOKB
25870235 ↗ Homozygous NOTCH3 null mutation and impaired NOTCH3 signaling in recessive early-onset arteriopathy and cavitating leukoencephalopathy. ONCOKB